Mark Worthington, General Counsel and CCO at Athira Pharma, Inc. (ATHA), sold 876 shares at $6.88 ($6K) on 2026-01-02, disclosed to the SEC on 2026-01-05.
Open-market sale of $6k ATHA by General Counsel and CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATHA | SELL | 2025-01-03 | $5K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $1K | — | Filing → |
| ATHA | SELL | 2024-02-16 | $7K | — | Filing → |